GENE ONLINE|News &
Opinion
Blog

Japan
Asahi Kasei Medical Ups CDMO Business in the US with Bionova Buy
2022-04-21
Shionogi and Aichi Prefecture Extends Cooperation on Preventing Drug Abuse
2022-04-08
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
World’s First Stem Cell Trial for Spinal Cord Injury Carried Out in Japan
2022-01-19
Roche Looks for Peptide-Like Small Molecules with Prism BioLab, joining Merck, Eisai and Boehringer Ingelheim
2022-01-05
As Regenerative Medicine Grows in Japan, Challenges Remain
2021-12-24
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
Are Decentralized Clinical Trials Taking Root in Japan?
2021-10-29
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
Japan’s Otsuka Inks $890M Deal with Sunovion to Target Neurological Illness
2021-10-01
Astellas, Seagen Cancer Drug Becomes First and Only Approved ADC For Advanced Urothelial Cancer in Japan
2021-09-28
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Japan’s Shionogi to Provide 120 Million Doses of COVID-19 Vaccines Annually
2021-07-08
Olympics to Go on Despite Cancellation Calls, US Adds Japan to “Do Not Travel” List
2021-05-26
1 2 3 4
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top